Double muscling in cattle is caused by mutations affecting the
myostatin gene, which normally regulates skeletal muscle growth. Animals with disrupted myostatin function develop significantly increased muscle mass, resulting in higher lean meat yields. Naturally occurring double muscling has been identified in several cattle breeds. The
Piedmontese breed, first documented in Italy in 1897, and the
Parthenaise, identified in France in 1893, both carry myostatin mutations associated with hypermuscularity. Another well-known example is the
Belgian Blue, which originated in central and upper Belgium and was established as a distinct breed in the early 20th century. Historically, Belgian Blue cattle were divided into beef and dairy strains, but modern breeding has focused almost exclusively on beef production. Although relatively recent in the United States, the breed has gained acceptance among cattle producers. The molecular basis of double muscling was clarified in 1997 with the discovery of myostatin by
Se-Jin Lee and
Alexandra McPherron. Their research demonstrated that mice lacking functional myostatin developed muscle mass two to three times greater than that of normal mice. Later that year, Lee and McPherron identified naturally occurring disruptions of the myostatin locus in Piedmontese and Belgian Blue cattle, confirming the genetic basis of hypermuscularity in these breeds. Subsequent research by Lee showed that myostatin deficiency was also associated with reduced white fat deposition and that excessive myostatin activity could induce a phenotype resembling
cachexia. He further demonstrated that additional molecules within the transforming growth factor beta (TGF-β) signalling pathway, including activins and follistatin, also play important roles in the regulation of skeletal muscle mass. These findings prompted interest in myostatin as a potential therapeutic target. Although no definitive clinical applications have yet been established, myostatin inhibition has been investigated for possible benefits in conditions characterised by muscle wasting, including muscular dystrophy, cancer and chronic kidney disease. Selective breeding for double muscling has been pursued primarily to increase meat yield and reduce fat content. Double-muscled cattle generally exhibit reduced backfat thickness and higher carcass yields compared with normally muscled animals. Meat from double-muscled cattle is also typically more tender. However, the condition is associated with husbandry challenges, including increased calving difficulties and specific management requirements. As a result, the use of double-muscled genetics remains a balance between production efficiency and animal welfare considerations within the
meat industry. ==Negative effects==